International Journal of Oncology

Additive inhibitory effects of retinoids and interferon-alpha on the growth of human cervical carcinoma cells
pp. 5-13(9)
Authors: Lotan, R; Trizna, Z; Zou, C; Lotan, D; Mitchell, M; Zou, C

Dexniguldipine hydrochloride inhibits growth of human pancreatic adenocarcinoma cells and expression of protein kinase C isoforms alpha and zeta
pp. 15-20(6)
Authors: Qin, Y; Tang, Y; Schally, A; Beckman, B

Role of HPV in tumorigenesis of oral keratinocytes
pp. 21-28(8)
Authors: Gujuluva, C; Shin, K; Park, N

Quantitative analysis of vascular endothelial growth factor expression in chronic lymphocytic leukaemia
pp. 29-34(6)
Authors: Baban, D; Murray, J; Earl, H; Kerr, D; Seymour, L

Down modulation of tumor-associated proteolytic activity by n-butanol in cultured murine mammary adenocarcinoma cells
pp. 35-39(5)
Authors: Ghiso, J; Farias, E; Fernandez, D; Klein, S; Alonso, D; Joffe, E

Simian virus 40-, but not human papillomavirus-, transformation of prostatic epithelial cells results in loss of growth-inhibition by 1,25-dihydroxyvitamin D-3
pp. 41-47(7)
Authors: Gross, C; Skowronski, R; Plymate, S; Rhim, J; Peehl, D; Feldman, D

Analysis of cytokine gene expression in squamous cell carcinoma of the head and neck
pp. 49-56(8)
Authors: Sabourin, C; Wang, Q; Mallery, S; Nicholson, R; Gopalakrishnan, R; Lang, J; Schuller, D; Stoner, G

Alteration of sensitivity to cis-diamine(glycolate)-platinum(II) (254-S) in oral tumor xenografts following multiple applications
pp. 57-63(7)
Authors: Sai, S; Kumazawa, H; Tachikawa, T; Yamashita, T; Kawamoto, K

The non-uniform repair of active and inactive chromatin domains (review)
pp. 65-75(11)
Author: Boulikas, T

A unified model explaining the preferential repair of active over inactive genes and of the transcribed over the nontranscribed strand
pp. 77-84(8)
Author: Boulikas, T

Comparative analysis of p16/CDKN2, p53 and ras gene alterations in human non-small cell lung cancers, with and without associated pulmonary asbestosis
pp. 85-90(6)
Authors: Hayashi, I; Konishi, N; Matsuda, H; Tsuzuki, T; Tao, M; Kitahori, Y; Tokuyama, T; Yoneda, T; Narita, N; Hiasa, Y

Cell cycle dependence of drug initiated apoptosis in HL-60 cells
pp. 91-96(6)
Authors: Endresen, P; Prytz, P; Aarbakke, J

Relationship between expression of plasminogen activator system and metastatic ability in human cancers
pp. 97-105(9)
Authors: NoguchiTakino, M; Endo, Y; Yonemura, Y; Sasaki, T

Detection of RB, p16/CDKN2 and p15(INK4B) gene alterations with immunohistochemical studies in human prostate carcinomas
pp. 107-112(6)
Authors: Konishi, N; Hiasa, Y; Tsuzuki, T; Matsuda, H; Tao, M; Nakamura, M; Naito, H; Kitahori, Y; Shiraishi, T; Yatani, R; Shimazaki, J; Lin, J

Flow cytometric DNA ploidy and recurrence development in squamous cell carcinoma of the oral cavity
pp. 113-116(4)
Authors: Hemmer, J; VanHeerden, W; Raubenheimer, E; Kreidler, J; Schon, E

Possible inhibitory effects of promotion stage treatment with thymosin fraction 5 on N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated urinary tract carcinogenesis in NON/Shi mice
pp. 117-124(8)
Authors: Murai, T; Mori, S; Hato, F; Kinoshita, Y; Fukushima, S

Screening of peptides which suppress the proliferation of transformed cells
pp. 125-129(5)
Authors: Hiwasa, T; Soeda, C; Takanohashi, S; Kobayashi, H; Suzuki, A; Ueyama, T; Ike, Y

Signaling pathways regulated by Rho-like proteins
pp. 131-138(8)
Author: Collard, J

A comparison of the detection of activated c-Ki-ras genes by mismatch specific oligonucleotide hybridisation analysis and enriched PCR in colorectal adenocarcinomas
pp. 139-143(5)
Authors: Elnatan, J; Goh, H; Smith, D

Effects of linoleic acid and eicosanoid synthesis inhibitors on the growth and c-myc oncogene expression of human breast cancer cells
pp. 145-151(7)
Authors: Earashi, M; Endo, Y; Obata, T; Minami, M; Noguchi, M; Miyazaki, I; Sasaki, T

Serum levels of the type IV collagen 7s domain in patients with chronic viral liver diseases
pp. 153-157(5)
Authors: Shimamura, T; Nakajima, Y; Une, Y; Uchino, J

Characterisation of cellular changes which influence progression of human papillomavirus type-16 immortalised keratinocytes to anchorage-independent phenotype
pp. 159-167(9)
Authors: Bouvard, V; Massimi, P; Banks, L

Resistance to tumor necrosis factor-induced apoptosis in mouse fibroblasts is a genetically dominant phenotype
pp. 169-173(5)
Authors: Fernandez, A; McConkey, D; Ananthaswamy, H

Pilot study of cytokine profiles in prostate cancer patients undergoing proton or conventional radiotherapy
pp. 175-181(7)
Authors: Gridley, D; Slater, J; Yonemoto, L; Miller, D; Rossi, C; Archambeau, J; Andres, M; Oey, M; Slater, J

Optimal therapy of malignant pleural effusions
pp. 183-190(8)
Authors: Lynch, T; Kalish, L; Mentzer, S; Decamp, M; Strauss, G; Sugarbaker, D

Expression of basic fibroblast growth factor in colorectal carcinoma
pp. 191-195(5)
Authors: Gagandeep, S; Green, B; Galzie, Z; Poston, G; Sutton, R; Taylor, B; Kinsella, A

Characterization of the tumor-promoting activity of m-chloroperoxybenzoic acid in SENCAR mouse skin and its inhibition by gallotannin, oligomeric proanthocyanidin, and their monomeric units
pp. 197-206(10)
Authors: Chen, G; Perchellet, E; Gao, X; Johnson, F; Davis, A; Newell, S; Hemingway, R; Bottari, V; Perchellet, J